A59L (p.Ala59Leu) variant of KRAS (GTPase KRas)

A59L (p.Ala59Leu) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Cardiofaciocutaneous syndrome 2. The available variant effect predictions contribute to a CATVariant prioritization score of 1.00 / 1. The record also includes experimental measurements, published literature, and structural context.

A59L (p.Ala59Leu) variant details